A randomized controlled study of wearable devices combined with Baduanjin in the management of movement in metabolic syndrome

Guangdong Provincial Hospital of Traditional Chinese Medicine0 个研究点开始时间: 待定最近更新: 2023年2月20日

适应症

试验速览

暂无简介。

•?Age between 18 and 70 years old.
•?Patients in the outpatient clinic and ward of the Department of Endocrinology of Guangdong Provincial Hospital of Traditional Chinese Medicine.
•?Patients who meet the diagnosis of metabolic syndrome; and BMI = 24 kg/m2 .
•?Those who signed the informed consent form.

•? Severe cardiac, hepatic and renal insufficiency (blood creatinine clearance <30 ml/min, alanine aminotransferase =2.5 times the upper limit of normal, total bilirubin =1.5 times the upper limit of normal; chronic cardiac insufficiency, cardiac function class III and above).
•?Those who are not suitable for exercise such as severe myocardial ischemia, severe hypertensive disease and unstable blood sugar.
•?Those who cannot cooperate with exercise such as post-stroke, joint and muscle diseases, lumbar spine diseases, etc.
•?Secondary lipid, blood pressure and glucose abnormalities.
•?Type 1 diabetes.
•?Hyperthyroidism or hypothyroidism.
•?Taking weight-impacting drugs such as glucocorticoids, birth control pills and diet pills.
•?Those who cannot understand the content of the study and have difficulty accepting the research protocol.

发起方

Guangdong Provincial Hospital of Traditional Chinese Medicine